ProMIS Neurosciences
PMN
12 hedge funds and large institutions have $1.13M invested in ProMIS Neurosciences in 2022 Q3 according to their latest regulatory filings, with 12 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.1% more ownership
Funds ownership: 0% → 0.1% (+0.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NFC
Northeast Financial Consultants
Westport,
Connecticut
|
+$589K |
| 2 |
IC
IEQ Capital
Foster City,
California
|
+$231K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$84.6K |
| 4 |
CAM
Claret Asset Management
Montreal,
Quebec, Canada
|
+$72.6K |
| 5 |
JP Morgan Chase
New York
|
+$45.1K |
Top Sellers
PMN Hedge Fund Activity: Q3 2022 in Review
12 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in ProMIS Neurosciences (PMN) for Q3 2022, worth a combined $1.13M.
Buyers outnumbered sellers: 12 funds opened new PMN positions and 0 closed out — a net gain of 12 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Northeast Financial Consultants, opening a new position worth an estimated $589K.
- 12 institutional investors held ProMIS Neurosciences (PMN) as of Q3 2022, up from 0 in Q2 2022.
- Funds reported $1.13M of ProMIS Neurosciences stock for Q3 2022.
- 12 funds opened new ProMIS Neurosciences positions in Q3 2022 and 0 closed out, a net change of +12 holders.
- The largest ProMIS Neurosciences buyer in Q3 2022 was Northeast Financial Consultants, an estimated $589K added.
Based on aggregated 13F filings for Q3 2022.